Filing Details
- Accession Number:
- 0001237648-22-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-27 12:45:04
- Reporting Period:
- 2022-12-22
- Accepted Time:
- 2022-12-27 12:45:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1038133 | Heska Corp | HSKA | In Vitro & In Vivo Diagnostic Substances (2835) | 770192527 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1570492 | S. Kevin Wilson | 3760 Rocky Mountain Avenue Loveland CO 80538 | Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-22 | 2,299 | $59.65 | 154,913 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-12-22 | 105 | $59.64 | 155,018 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-12-22 | 796 | $59.62 | 155,814 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-12-22 | 240 | $59.57 | 156,054 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 162,763 | Indirect | by Cuattro, LLC |
Common Stock | 9,000 | Indirect | by Spouse |
Common Stock | 138,743 | Indirect | by Wilson Family Tr. |
Footnotes
- The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 1, 2022.